Akebia Therapeutics
AKBA
$1.14
Share price
-3.39%
Change (1 day)
4.59%
Change (1 year)
Categories
Market capitalization of Akebia Therapeutics (AKBA)
Market cap: $0.23 Billion
As of May 2024 Akebia Therapeutics has a market cap of $0.23 Billion. This makes Akebia Therapeutics the world's 6818th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Akebia Therapeutics from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.23 B | 2.28% |
| 2023 | $0.23 B | 120.08% |
| 2022 | $0.10 B | -73.16% |
| 2021 | $0.39 B | -2.3% |
| 2020 | $0.40 B | -47.37% |
| 2019 | $0.76 B | 18.97% |
| 2018 | $0.64 B | -8.04% |
| 2017 | $0.70 B | 76.18% |
| 2016 | $0.39 B | 0.71% |
| 2015 | $0.39 B | 67.07% |
| 2014 | $0.23 B |
End of Day market cap according to different sources
On May 15th, 2024 the market cap of Akebia Therapeutics was reported to be:
$0.25 Billion
$0.25 Billion
$0.24 Billion
$0.24 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $371.30 B | 155,296.11% | 🇺🇸 USA |
 Novartis NVS | $209.52 B | 87,591.55% | 🇨🇭 Switzerland |
 Amgen AMGN | $168.82 B | 70,556.75% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.33 B | 38.33% | 🇺🇸 USA |